(Hypertension. 2000;35:726.)
© 2000 American Heart Association, Inc.
Scientific Contributions |
From the Department of Pharmacology (J.-P.G.), Yale University School of Medicine, Boyer Center for Molecular Medicine, New Haven, Ct; the Department of Pharmacology (G.A.R.), Centro de Ciencias Biologicas, Universidade Federal de Santa Catarina, Florianopolis, Brazil; and the Department of Anatomy and Cell Biology (G.B.) and the Department of Pharmacology (P.DO.-J.), Medical School, Université de Sherbrooke, Sherbrooke, Québec, Canada.
Correspondence to Pedro DOrléans-Juste, Department of Pharmacology, Medical School, Université de Sherbrooke, Sherbrooke, Québec J1H 5N4, Canada. E-mail labpdj{at}courrier.usherb.ca
AbstractThe precursor of endothelin-1, big endothelin-1, is considered to be a more reliable marker of systemic production of vasoactive peptide. However, it is largely unclear whether ETB receptordependent clearance and endothelium-derived relaxing factors affect the precursor in a similar manner to mature ET-1. These ETB-dependent modulations of big ET-1 and big ET-2 pressor properties were therefore studied in the anesthetized rabbit. When injected into the left cardiac ventricle, ET-1 and ET-2 (0.01 to 1 nmol/kg) each induced biphasic responses (a depressor followed by a pressor response), whereas big ET-1 and big ET-2 (0.1 to 3 nmol/kg) caused only protracted pressor responses. The highest dose of big ET-1 caused significantly greater responses than ET-1, ET-2, or big ET-2. A selective ETA receptor antagonist, BQ-123 (1 mg/kg), markedly reduced pressor responses to all 4 peptides, whereas blockade of ETB receptors with BQ-788 (0.25 mg/kg) sharply potentiated the responses to ET-1, ET-2, and big ET-1, but not to big ET-2. Indomethacin (10 mg/kg) sharply potentiated the pressor response to ET-1 (1 nmol/kg), but not big ET-1, at all time points. In control animals, ET-1, but not big ET-1, also triggered an indomethacin-sensitive increase in circulating prostacyclin. Finally, systemically administered big ET-1, but not big ET-2, induced a phosphoramidon-sensitive increase in plasma IR-ET. Our results suggest a significant limiting role of ETB receptors on pressor responses to big ET-1. In contrast, the same receptor entities do not modulate the hemodynamic properties of the ET-2 precursor, given that, unlike big ET-1, it is poorly converted in the pulmonary or systemic circulation in anesthetized rabbits.
Key Words: endothelin endothelium-derived relaxing factor endothelin-converting enzyme prostacyclin chromatography receptors
This article has been cited by other articles:
![]() |
J.-C. Honore, M.-H. Fecteau, I. Brochu, J. Labonte, G. Bkaily, and P. D'Orleans-Juste Concomitant antagonism of endothelial and vascular smooth muscle cell ETB receptors for endothelin induces hypertension in the hamster Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1258 - H1264. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-H. Fecteau, J.-C. Honore, M. Plante, J. Labonte, G. A. Rae, and P. D'Orleans-Juste Endothelin-1 (1-31) Is an Intermediate in the Production of Endothelin-1 After Big Endothelin-1 Administration In Vivo Hypertension, July 1, 2005; 46(1): 87 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. N. Onuoha, E. K. Alpar, and J. Gowar Endothelin-1 Levels in Severe Burn Injuries Arch Surg, December 1, 2000; 135(12): 1418 - 1421. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |